These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17848891)

  • 21. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses.
    Engler RJ; Nelson MR; Klote MM; VanRaden MJ; Huang CY; Cox NJ; Klimov A; Keitel WA; Nichol KL; Carr WW; Treanor JJ;
    Arch Intern Med; 2008 Dec; 168(22):2405-14. PubMed ID: 19064822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune response to measles vaccine in 6 month old infants in Papua New Guinea.
    Kurubi J; Vince J; Ripa P; Tefuarani N; Riddell M; Duke T
    Trop Med Int Health; 2009 Feb; 14(2):167-73. PubMed ID: 19171008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination.
    Cohen BJ; Doblas D; Andrews N
    Vaccine; 2008 Nov; 26(50):6392-7. PubMed ID: 18834911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Placental transfer of measles antibodies: effect of gestational age and maternal vaccination status.
    Linder N; Tallen-Gozani E; German B; Duvdevani P; Ferber A; Sirota L
    Vaccine; 2004 Mar; 22(11-12):1509-14. PubMed ID: 15063576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Standardization of neutralization tests using the COBL cell line and comparison with the particle agglutination test for measles serology].
    Korukluoğlu G; Yalçinkaya T; Ozkaya E; Kurtoğlu D; Gözalan A; Miyamura K
    Mikrobiyol Bul; 2002 Apr; 36(2):193-9. PubMed ID: 12652872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys.
    Nigatu W; Samuel D; Cohen B; Cumberland P; Lemma E; Brown DW; Nokes J
    Vaccine; 2008 Sep; 26(37):4769-74. PubMed ID: 18644417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination coverage against measles in German-born and foreign-born children and identification of unvaccinated subgroups in Germany.
    Poethko-Müller C; Ellert U; Kuhnert R; Neuhauser H; Schlaud M; Schenk L
    Vaccine; 2009 Apr; 27(19):2563-9. PubMed ID: 19428862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi.
    Helfand RF; Witte D; Fowlkes A; Garcia P; Yang C; Fudzulani R; Walls L; Bae S; Strebel P; Broadhead R; Bellini WJ; Cutts F
    J Infect Dis; 2008 Nov; 198(10):1457-65. PubMed ID: 18828743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-dependent differences in IgG isotype and avidity induced by measles vaccine received during the first year of life.
    Nair N; Gans H; Lew-Yasukawa L; Long-Wagar AC; Arvin A; Griffin DE
    J Infect Dis; 2007 Nov; 196(9):1339-45. PubMed ID: 17922398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity and safety of Abhay M and M-vac vaccines in healthy infants: a phase III multicentric randomized single blind trial.
    Zodpey SP; Agarkhedkar SR; Reddy GA; Rao MI; Shenoy UV; Murthy SR; Maiya PP
    Indian J Public Health; 2008; 52(1):5-10. PubMed ID: 18700714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measles cases in highly vaccinated population of Novosibirsk, Russia, 2000-2005.
    Atrasheuskaya AV; Kulak MV; Neverov AA; Rubin S; Ignatyev GM
    Vaccine; 2008 Apr; 26(17):2111-8. PubMed ID: 18343536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of Edmonston-Zagreb measles vaccine.
    Parmar VR; Sood AK; Goyal A; Sharma V; Singh T
    Indian Pediatr; 1996 Oct; 33(10):845-50. PubMed ID: 9057383
    [No Abstract]   [Full Text] [Related]  

  • 33. Persistence of mumps antibodies after 2 doses of measles-mumps-rubella vaccine.
    LeBaron CW; Forghani B; Beck C; Brown C; Bi D; Cossen C; Sullivan BJ
    J Infect Dis; 2009 Feb; 199(4):552-60. PubMed ID: 19113988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Could the MMR vaccine replace the measles vaccine at one year of age in Egypt?
    Abbassy AA; Barakat SS; Abd El Fattah MM; Said ZN; El Metwally HA
    East Mediterr Health J; 2009; 15(1):85-93. PubMed ID: 19469430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak.
    Rubin SA; Qi L; Audet SA; Sullivan B; Carbone KM; Bellini WJ; Rota PA; Sirota L; Beeler J
    J Infect Dis; 2008 Aug; 198(4):508-15. PubMed ID: 18558869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan.
    Iwai M; Takizawa T; Nakayama T; Matsuura K; Yoshida H; Hasegawa S; Obara M; Horimoto E; Kurata T; Horie H
    Scand J Infect Dis; 2008; 40(3):247-53. PubMed ID: 17907043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroprevalence of rubella among Jordanian women of childbearing age.
    Jarour N; Hayajneh WA; Balbeesi A; Otoom H; Al-Shurman A; Kharabsheh S
    Vaccine; 2007 May; 25(18):3615-8. PubMed ID: 17280747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine.
    Hepburn MJ; Kortepeter MG; Pittman PR; Boudreau EF; Mangiafico JA; Buck PA; Norris SL; Anderson EL
    Vaccine; 2006 Apr; 24(15):2843-9. PubMed ID: 16494976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up.
    Davidkin I; Jokinen S; Broman M; Leinikki P; Peltola H
    J Infect Dis; 2008 Apr; 197(7):950-6. PubMed ID: 18419470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination.
    Cohen BJ; Audet S; Andrews N; Beeler J;
    Vaccine; 2007 Dec; 26(1):59-66. PubMed ID: 18063236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.